pan-Canadian Oncology Drug Review Final Clinical Guidance Report Carfilzomib (Kyprolis) for Multiple Myeloma
![Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period - Sun Hee Kim, Irene Krämer, 2019 Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period - Sun Hee Kim, Irene Krämer, 2019](https://journals.sagepub.com/cms/10.1177/1078155217735881/asset/images/large/10.1177_1078155217735881-fig3.jpeg)
Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period - Sun Hee Kim, Irene Krämer, 2019
![Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period - Sun Hee Kim, Irene Krämer, 2019 Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period - Sun Hee Kim, Irene Krämer, 2019](https://journals.sagepub.com/cms/10.1177/1078155217735881/asset/images/large/10.1177_1078155217735881-fig5.jpeg)
Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period - Sun Hee Kim, Irene Krämer, 2019
![Amgen gets cosier with Dr. Reddy's, adding three marketed drugs to Indian partnership | Fierce Pharma Amgen gets cosier with Dr. Reddy's, adding three marketed drugs to Indian partnership | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/2016-09/Dr_Reddys_0.jpg?VersionId=.wjsaamgn6iPw9IRjXTzDxypyqKtXUiq)
Amgen gets cosier with Dr. Reddy's, adding three marketed drugs to Indian partnership | Fierce Pharma
Characterization of the Molecular Mechanism of the Bone-Anabolic Activity of Carfilzomib in Multiple Myeloma | PLOS ONE
![March's top stories: GSK's preterm labour trial, Amgen and Onyx's Kyprolis drug - Clinical Trials Arena March's top stories: GSK's preterm labour trial, Amgen and Onyx's Kyprolis drug - Clinical Trials Arena](https://www.drugdevelopment-technology.com/wp-content/uploads/image-digitalinsightresearch/Archive/nri/Drug%20development/amgentop.jpg)
March's top stories: GSK's preterm labour trial, Amgen and Onyx's Kyprolis drug - Clinical Trials Arena
![Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period - Sun Hee Kim, Irene Krämer, 2019 Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period - Sun Hee Kim, Irene Krämer, 2019](https://journals.sagepub.com/cms/10.1177/1078155217735881/asset/images/large/10.1177_1078155217735881-fig1.jpeg)
Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period - Sun Hee Kim, Irene Krämer, 2019
![Proteasome Inhibitors for Treating Multiple Myeloma: R&D Status | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives Proteasome Inhibitors for Treating Multiple Myeloma: R&D Status | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives](https://en.huatengsci.com/usr/uploads/3/202006/Oprozomib.jpg)